Back

POC-CCA3: Reducing batch-to-batch variation in the WHO-endorsed POC-CCA for Schistosoma mansoni and improving test interpretation

Entezami, M.; Kabbas-Pienango, E.; Arinaitwe, M.; Abdoel, T.; Hoekstra, P. T.; Alonso, S.; Adriko, M.; Paulussen, R.; van Dam, G. J.; Lamberton, P. H. L.; Prada, J. M.

2025-06-05 infectious diseases
10.1101/2025.06.04.25328804 medRxiv
Show abstract

BackgroundWorld Health Organization (WHO) schistosomiasis control programmes typically rely on Kato-Katz microscopy (KK) to detect Schistosoma mansoni eggs, although KK has limited sensitivity, especially in low-intensity infections. The WHO-endorsed point-of-care circulating cathodic antigen test (POC-CCA) is more sensitive but lacks the complete specificity of KK and has suffered significant batch-to-batch variability, compromising reliability. We evaluated an updated version, POC-CCA3, with the aim of addressing this batch-to-batch variation. MethodsThe POC-CCA3 employs recombinant monoclonal antibodies for Schistosoma CCA detection. School-aged children (n=870) in moderate (Tororo) and high endemicity (Mayuge) settings in Uganda were tested using KK, POC-CCA, and POC-CCA3 tests over three consecutive days. Data were analysed using descriptive statistics and Bayesian Latent Class Analysis, estimating diagnostic performance including sensitivity, specificity, receiver operating characteristic curves, and batch-specific variation and day-to-day variation. ResultsModel median prevalence estimates were 91.4% (Mayuge) and 31.2% (Tororo). A single POC-CCA3 test at G-score threshold 4 achieved estimated sensitivity and specificity, respectively, 86.3% and 92.9% in moderate and 88.1% and 95.5% in high endemicity settings. POC-CCA3 has a small increase in the probability of meeting the WHO TPP for monitoring and evaluation compared to the original POC-CCA. Overall diagnostic performance (AUC >94.2%) was higher compared to POC-CCA, with markedly lower batch-to-batch variation. Conclusions/Next stepsThe POC-CCA3 demonstrates superior performance and greater consistency compared to POC-CCA. A G-score threshold of 4 maximises performance towards WHO target product profile (TPP) requirements. However, neither test consistently meets WHO specificity requirements from a single sample, suggesting the need for continued refinement.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.